NCT04171310View on ClinicalTrials.gov

Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions

Multiple Sclerosis

Interventions

DRUG

SAR442168

Pharmaceutical form:oral solution Route of administration: Oral

Trial Locations (1)

Unknown

Investigational Site Number 8260001, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY